Can Wegovy Cause High Liver Enzymes?

Step 1: understand what 'raised liver enzymes' actually means in this context

Liver enzymes (most commonly ALT and AST) are proteins released into the bloodstream when liver cells are under stress. A raised reading on a blood test does not automatically mean liver damage; transient rises happen with many medicines, dietary changes and even intense exercise. In the STEP clinical programme that led to Wegovy's approval, liver enzyme elevations were noted in a subset of participants, but the majority were mild and self-limiting. The NHS medicines page for semaglutide lists liver-related effects among the things to discuss with a clinician, though it does not classify hepatotoxicity as a common adverse event.

Context matters here. Many people who use Wegovy carry excess weight, which itself raises the risk of non-alcoholic fatty liver disease and associated enzyme elevations. Separating the medicine's effect from the underlying condition is genuinely difficult, and the published trials were not designed to resolve that question neatly. What the data do support is that for most people the liver picture either stays stable or improves with weight loss, which semaglutide produces in meaningful amounts. If you want to understand the full picture, our guide covering whether semaglutide can cause elevated liver enzymes walks through the evidence in detail. The relationship is more nuanced than a simple cause-and-effect story.

If you are already aware of abnormal liver results before starting treatment, tell your prescriber at the outset. They will weigh that up alongside the rest of your health picture when deciding whether Wegovy is appropriate. Our clinical team at nume reviews every application personally, not via an automated screening tool.

Step 2: factor in the newer evidence on semaglutide and liver disease

A significant development complicates the 'Wegovy raises liver enzymes' framing. On 3 July 2026 the MHRA conditionally approved semaglutide (Wegovy) as a treatment for MASH (metabolic dysfunction-associated steatohepatitis) a form of progressive fatty liver disease with moderate-to-advanced fibrosis. That approval, covered in detail on the gov.uk news announcement, means that in the right clinical population semaglutide actively reduces liver inflammation rather than causing it.

This does not mean Wegovy is harmless for every liver condition. The MASH indication applies to a specific patient group assessed and monitored by specialists. For weight management (the indication nume prescribes for) the prescriber still needs to know your liver history. If you have cirrhosis, active hepatitis or other significant liver disease, Wegovy's suitability requires specialist input, and the clinical review at consultation is the right moment to surface that.

The broader picture from semaglutide's interaction with liver enzymes is therefore genuinely two-sided: some enzyme fluctuation can occur, particularly early in treatment, while the drug's weight-lowering effect tends to benefit liver health over time. Uncertainty remains about rarer, more severe reactions, and anyone with a complex liver history should discuss this with a hepatologist or gastroenterologist, not just their weight-management prescriber.

Step 3: know the warning signs that need prompt medical attention

Most people will never experience a liver-related problem on Wegovy. But a few symptoms should prompt you to contact a doctor the same day rather than waiting for a scheduled review. Yellowing of the skin or the whites of the eyes (jaundice), dark amber-coloured urine, very pale stools, or persistent pain in the upper right side of the abdomen can all signal that the liver is under unusual stress. These are rare on semaglutide, but they are not features to monitor passively.

One thing our prescribers mention regularly is the pancreatitis risk, which the MHRA highlighted formally in a Drug Safety Update in January 2026. Pancreatitis can cause enzyme levels including some liver markers to rise, and its hallmark (severe stomach pain that radiates through to the back, not eased by sitting still) needs urgent medical attention. It is a separate issue from liver enzyme changes, but the symptoms can overlap in ways that a blood test will clarify. Some people also notice cardiovascular changes during treatment, and if you are concerned about your pulse, our page on whether Wegovy can cause a high heart rate explains what the evidence says. You can report any suspected adverse effect via the MHRA Yellow Card scheme, which helps regulators track signals that emerge in real-world use rather than trials alone.

If you are unsure whether what you are feeling is a side effect worth reporting, our aftercare team is available seven days a week. We will not tell you what it is, but we will help you decide whether to speak to a GP or seek urgent care.

Step 4: specific situations that change the calculation

A few circumstances make a conversation with a specialist non-negotiable rather than optional. Pregnancy is one: Wegovy is not recommended during pregnancy, breastfeeding or when actively trying to conceive. If there is any chance you could become pregnant while on treatment, discuss contraception (and the specific guidance around oral contraceptives and semaglutide) before starting. Our page on Wegovy and pregnancy covers this in detail.

Alcohol use is another variable. Heavy or regular alcohol intake puts independent pressure on the liver, and combining that with a medicine that can itself produce mild enzyme fluctuations means blood tests are worth monitoring more actively. Your prescriber can advise on a sensible baseline. People with type 2 diabetes should also note that changes in liver enzyme profiles are common in that population regardless of treatment, which is one reason clinical review before every repeat prescription matters. There is no auto-renewal at nume; your notes are read again before the next order goes out.

Finally, if you are researching this because you noticed a raised enzyme reading on a recent blood test and are mid-treatment, contact the team who prescribed for you first. Do not stop semaglutide abruptly without clinical advice. Explore the full picture of how Wegovy affects liver enzymes and, if you are still deciding whether treatment is right for you, check your eligibility with our prescribers as a starting point.